The proposed mechanism linking GLP-1 agonists to gallbladder problems primarily involves reduced gallbladder motility and bile stasis
A: Yes, according to FDA prescribing information, all GLP-1 medications available through Ro are administered as subcutaneous (under-skin) injections: Frequency : Once weekly (same day each week) Injection sites : Abdomen, thigh, or upper arm (rotate sites) Needle size : Very small (similar to insulin needles) Administration time : Less than 1 minute Most members report that injection anxiety diminishes significantly after first few doses
We cant assume that patients will get worsening eye disease while on these drugs, says Dr
Our Ozempic attorneys have recovered millions for clients harmed by dangerous drugs and corporate negligence
In some cases, referral to cardiology may be appropriate, particularly if an underlying arrhythmia is suspected or if you have pre-existing cardiovascular disease
And we're now in a situation where we don't know if we're dealing with pure placebo effect or we are dealing with real effects
